Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 713 transactions and raising C$86.1 billion on behalf of our clients in fiscal 20211.2.

Filter our transactions* using the categories below:

OrthogenRx, Inc.
Pending Completion

OrthogenRx, Inc.

Financial Advisor (Sell side)
HEALTHCARE M&A ADVISORY US
View transaction detail
Apollo Healthcare Corp.
C$327m
Pending Completion

Apollo Healthcare Corp.

Financial Advisor
HEALTHCARE M&A ADVISORY CANADA
View transaction detail
Privia Health Group, Inc.
US$174m
November 2021

Privia Health Group, Inc.

Co-Manager (Follow-on)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Definitive Healthcare
US$396m
November 2021

Definitive Healthcare

Co-Manager (Follow-on)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Cardiol Therapeutics, Inc.
US$50m
November 2021

Cardiol Therapeutics, Inc.

Lead Left Bookrunner
HEALTHCARE EQUITY CAPITAL MARKETS CANADA US
View transaction detail
ObsEva
$135m
October 2021

ObsEva

Committed debt facility
DEBT ADVISORY & RESTRUCTURING HEALTHCARE UK CANADA
Lucid Diagnostics Inc.
US$70m
October 2021

Lucid Diagnostics Inc.

Joint Bookrunner (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
PharmaCann
October 2021

PharmaCann

Financial Advisor (Buy side)
CANNABIS HEALTHCARE M&A ADVISORY US
View transaction detail
Ares Management
October 2021

Ares Management

Financial Advisor (Buy side)
HEALTHCARE M&A ADVISORY UK FRANCE
View transaction detail
Babylon Holdings Limited
US$4b
October 2021

Babylon Holdings Limited

Financial/Capital Markets Advisor (SPAC)
HEALTHCARE SPAC M&A ADVISORY UK US
View transaction detail
 InfraVia Capital Partners
September 2021

InfraVia Capital Partners

Exclusive Financial Advisor
M&A ADVISORY HEALTHCARE FRANCE
View transaction detail
Vicarious Surgical Inc.
US$872m
September 2021

Vicarious Surgical Inc.

Financial/Capital Markets Advisor (SPAC)
HEALTHCARE M&A ADVISORY EQUITY CAPITAL MARKETS SPAC US
View transaction detail
  1. Company information as of March 31, 2021
  2. Transactions valued above C$1.5 million

* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description

How can we help?

If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.